Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.2462G>A | p.Cys821Tyr | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
TGC | Cys | TAC | Tyr | G->A | Ts |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
cb EGF-like #09 | Disulfide bonds 811-821 (C3) | No | No |
At the mRNA level | On restriction map |
NA | New restriction site(s): none Lost restriction site(s): none |
Conservation (0-1) | SIFT (0-1) | UMD-predictor (0-100) |
---|---|---|
0.67 | 0.00 (pathogenous) | 100 (Pathogenous) |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
FRA01BOU F0594 I0631 | Proband | Female | de novo | FRANCE |
Phenotypic group | Disease |
NA | Classical MFS |
Symptom |
Reference ID | PubMed ID | Reference |
207 | - | Boileau C. (personnal communication 2013) |